Physician

Keyvan Rashidi, MD

According to 2025 Medicare claims, Keyvan Rashidi, MD (NPI: 1417303082) practices addiction medicine in the Cleveland, OH market, with the plurality of this provider's patient population coming from Ashtabula, OH. This provider's primary affiliated billing organization is COMMUNITY COUNSELING CENTER OF ASHTABULA COUNTY (NPI: 1720029622; TIN: 340901680) and primary practice location at 44004-4577.

Rashidi's data goes back to 2015 and runs through 2024. Part D data shows 137 prescription claims across 17 beneficiaries totaling $47,736 in drug costs, led by Buprenorphine-Naloxone (Buprenorphine Hcl/Naloxone Hcl). Open Payments data shows 4 records totaling $82. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider has fewer than 5 years of reported Medicare Part B carrier billing data, so a reliable trend cannot be assigned. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $3,426 to $47,736. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

No connected Part B records

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	N/R	N/R	N/R
2016	N/R	55	$3,426
2017	59	366	$25,220
2018	83	573	$32,023
2019	83	466	$22,107
2020	14	38	$3,925
2021	12	26	$522
2022	13	45	$1,786
2023	11	23	$1,263
2024	17	137	$47,736

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

No connected Part B code-level records for 2024.

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Buprenorphine-Naloxone	Buprenorphine Hcl/Naloxone Hcl	61	1,331	$17,347
Buprenorphine Hcl	Buprenorphine Hcl	12	280	$225

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	4	$82	Indivior Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Keyvan Rashidi, MD?

Tedicare shows public-source Medicare data for Keyvan Rashidi, MD (NPI 1417303082), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Keyvan Rashidi, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Keyvan Rashidi, MD?

Keyvan Rashidi, MD is linked to COMMUNITY COUNSELING CENTER OF ASHTABULA COUNTY (billing NPI 1720029622) in the available physician profile data.

Does Keyvan Rashidi, MD have Open Payments data?

Keyvan Rashidi, MD has 4 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.